Efficacy and Safety of Drotaverine Hydrochloride in Irritable Bowel Syndrome: A Randomized Double-Blind Placebo-Controlled Study

BACKGROUNDS/AIMS: To study the efficacy and safety of drotaverine hydrochloride (HCl) 80 mg tablet given thrice a day in the symptomatic relief of patients with irritable bowel syndrome (IBS). PATIENTS AND METHODS: The study was a multicentric, randomized, double-blind, placebo-controlled parallel g...

Descripción completa

Detalles Bibliográficos
Autores principales: Rai, Ramesh R., Dwivedi, Manisha, Kumar, Nirmal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271014/
https://www.ncbi.nlm.nih.gov/pubmed/25434320
http://dx.doi.org/10.4103/1319-3767.145331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271014/
https://www.ncbi.nlm.nih.gov/pubmed/25434320
http://dx.doi.org/10.4103/1319-3767.145331

Ejemplares similares